Biota Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

BOTA 2.40 -0.01 (-0.41%)
price chart
Biota Pharmaceuticals to Host Conference Call to Report Second Quarter Fiscal ...
ATLANTA, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) (the "Company"), a biopharmaceutical company focused on the discovery and development of products to prevent and treat serious and potentially life-threatening ...
Biota Pharmaceuticals Inc Stock Downgraded (BOTA)
The gross profit margin for BIOTA PHARMACEUTICALS INC is currently lower than what is desirable, coming in at 34.92%. It has decreased significantly from the same period last year.
Related articles »  
Biota Pharmaceuticals to Make Alpharetta, GA Its New Home
According to a company press release, Biota Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of anti-infective products to prevent and treat a number of serious and potentially life-threatening viral and ...
Biota Pharmaceuticals relos HQ to Atlanta  Atlanta Business Chronicle (blog)
Related articles »  
Short Interest of Biota Pharmaceuticals Inc Increases by 35.3%
The short interest in Biota Pharmaceuticals Inc (NASDAQ:BOTA) has increased from 161,672 on December 15,2014 to 218,661 on December 31,2014.
Massive Swings: Biota Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
Healthcare investors were presented with major movements in two small stocks today: Amicus Therapeutics (NASDAQ: FOLD ) popped almost 21% on strong phase 3 data for a Fabry disease drug, while Biota Pharmaceuticals (NASDAQ: BOTA ) collapsed ...
Related articles »  
Biota Pharmaceuticals Inc. And Venaxis Inc.: 2 Upcoming Biopharmaceuticals ...
Biota Pharmaceuticals, Inc. (NASDAQ:BOTA) is a biopharmaceutical company focused on the discovery and development of anti-infective products to prevent and treat a number of serious and potentially life-threatening infectious diseases.
Biota Pharmaceuticals: An Undervalued Long-Term Influenza Play (BOTA)
Biota is reducing headcount by 69% between June 2014 and June 2015, as well as closing its Melbourne facility, significantly decreasing cash burn.
Biota Pharmaceuticals to Host Conference Call to Report First Quarter ...
ATLANTA, Oct. 28, 2014 (GLOBE NEWSWIRE) -- Biota Pharmaceuticals, Inc. (Nasdaq:BOTA) ("Biota" or the "Company") announced today that management will host a conference call on Friday, November 7, 2014 at 9:00 a.m.
Related articles »  
Stocks Underperform for the Week: Biota Pharmaceuticals Inc , Tribune ...
Biota Pharmaceuticals Inc (NASDAQ:BOTA) has dropped 9.74% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 7.11% in the past 4 weeks.
34% Drop in Biota Pharmaceutical, Inc.'s Stock Price: Law Firm Investigates on ...
SAN DIEGO and NEW YORK, May 12, 2014 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP is investigating potential violations of federal securities laws on behalf of investors of Biota Pharmaceutical, Inc. BOTA, -2.82% Biota ...
Related articles »